基因分型
医学
淋巴瘤
肿瘤科
循环肿瘤DNA
微小残留病
内科学
疾病监测
疾病
弥漫性大B细胞淋巴瘤
基因型
等位基因
前瞻性队列研究
滤泡性淋巴瘤
癌症
基因检测
精确肿瘤学
免疫学
突变
生物信息学
作者
Joanna Alicja Krupka,Christiane Pott,Daniel James Hodson
出处
期刊:Blood
[Elsevier BV]
日期:2026-09-03
标识
DOI:10.1182/blood.2026033074
摘要
Diffuse Large B-cell lymphoma is an aggressive lymphoma in which management is constrained by incomplete molecular characterization and the absence of sensitive markers of treatment response. Cell-free DNA offers a noninvasive approach for tumor genotyping and minimal residual disease monitoring. Nevertheless, technical challenges persist, including low cfDNA abundance and the discrimination of low allele fraction variants from background noise. Tumor-informed assays tracking multiple genetic markers substantially improve sensitivity of disease monitoring. Standardization and prospective validation will facilitate routine clinical implementation.
科研通智能强力驱动
Strongly Powered by AbleSci AI